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Abstract
Background: Primary melanoma of the small bowel is extremely rare. Only a limited number of cases have been
described in the literature. Mostly, the small intestine is affected by metastatic tumors of other primary lesions,
especially cutaneous.
Case presentation: We report the case of a 75-year-old North African woman with a small bowel melanoma. The
diagnosis was made by histological examination and immunohistochemical profile matching after a segmental
small bowel resection. Postoperative investigations looking for cutaneous, gastrointestinal or ocular primary lesions
found no abnormalities.
Conclusions: The diagnosis of primary small bowel melanoma can be retained although it remains difficult to
exclude the possibility of metastatic melanoma.
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Background
Melanoma is a malignant tumor developed from mela-
nocytes which are usually located in the skin, the eye’s
choroid, the meninges, and the anal margin. Melanoma
of the gastrointestinal tract represent 1 to 3% of the
digestive cancers [1, 2], it is essentially a metastasis of a
cutaneous, ocular, or anal primary lesion [3]. Primary
melanoma of the small bowel is exceptional, only few
cases have been reported in the literature due to the
difficulty in excluding another primary cancer [2, 4].
Regardless of its primary or secondary character, intestinal
melanoma remains more aggressive with a poor prognosis
compared to other nondigestive locations. The median
overall survival is 4 to 6 months with a survival rate of less
than 10% at 5 years [3, 5].
With regard to therapeutic approach, there is no real
consensus in the curative treatment of primary melanoma
of the gastrointestinal tract. Surgery remains an essential
approach for this disease, since effective adjuvant systemic
therapies are without benefit for overall survival [6]. The
optimal surgical technique consists of a carcinologic re-
section of the tumor.
Case presentation
We report the case of a 75-year-old North African woman
with no notable medical history, admitted for pelvic pain
lasting for the last 4 months and unrelieved by analgesics;
the transit was undisturbed. The symptoms were aggra-
vated by melena and asthenia that motivated the medical
consultation. A clinical examination at admission found a
patient with a stable hemodynamic status, an abdominal
examination revealed a palpable and mobile pelvic mass.
Laboratory tests showed a hypochromic and microcytic
anemia with low hemoglobin and hematocrit levels rating
at 7.3 g/dL and 21%. An abdominal computed tomog-
raphy (CT) scan showed a large pelvic mass measuring
11 × 9 cm involving the distal small bowel loops, the
bladder dome, and the uterine body without peritoneal
effusion (Fig. 1). After primary care, our patient under-
went an exploratory laparotomy. The intraoperative
finding was a brownish pseudoaneurysmal mass of the
small bowel located 80 cm from the Treitz’s angle; this
mass was invading the bladder dome and the left ovary
and closely adhering to the uterus (Fig. 2). Limited
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small bowel resection with 10 cm margins on both sides
of the tumor extended to the left annexes and to a portion
of the bladder with end-to-end anastomosis was achieved.
The postoperative management was uneventful and our
patient was discharged on day 6. The surgical specimen
was 18 cm in length and included a black solid tumor with
exophytic growth infiltrating the small bowel wall until
the mucosa (Fig. 3). A histological examination revealed a
malignant proliferation of large cells with prominent
round nuclei and a cytoplasm with eosinophilic spots or
the seat of melanin pigments. Tumor necrosis was esti-
mated at 30%, the rest of the ileum was the seat of chronic
ileitis (Fig. 4). The immunohistochemical profile showed
an intense and diffuse cytoplasmic positivity for HMB-45
antigens and for PS-100, suggesting a malignant melan-
oma (Figs. 5 and 6). An etiological investigation in search
of a primary tumor of the small bowel melanoma was
negative, an anoscopy, examinations of eyes and skin with
multiple cutaneous biopsies were performed without find-
ing any melanoma lesion.
Discussion
Melanoma develops in the melanocytes, which are den-
dritic cells present in the skin, the eye, and the epithelium
of the nasal cavity, oropharynx, anus, vagina, and urinary
tract. In addition to these sites, it was proven by immuno-
peroxidase studies that melanocytes are present in Meck-
el’s diverticulum [7, 8]. Normally, the small intestine and
the colon do not contain melanocytes. Embryologically,
they arise from neural crest melanoblasts which migrate
to the distal ileum through the umbilical-mesenteric canal
[7, 9]. They differentiate by amine precursor uptake and
decarboxylation (APUD), and can undergo neoplastic
transformation in noncutaneous sites [10]. According to
this theory, the ileum is the most common site for the
development of primary melanoma of the small intestine,
although some authors still deny the existence of primary
melanoma in the gastrointestinal tract. They argue that
primary cutaneous tumors can regress before metastatic
manifestations or they are too small to be identified by
clinical and laboratory examinations [2]. Primary or sec-
ondary gastrointestinal melanoma is difficult to establish
resulting in many controversies [11].The gastrointestinal
Fig. 1 Computed tomography scan showing a pelvic mass measuring11 × 9 cm involving the distal small bowel loops, the bladder dome, and
the uterine body without peritoneal effusion
Fig. 2 Intraoperative finding revealing a pseudoaneurysmal tumor of
the small intestine involving the left ovary
Fig. 3 Limited small bowel resection extended to the left annexes
and to a portion of the bladder
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tract is the most common site of cutaneous melanoma
metastasis [4, 10]. Usually asymptomatic, metastases are
diagnosed at autopsy in 58% of patients with cutaneous
melanoma [9], they may be clinically detected only after
treatment of primary melanoma, or spontaneous regres-
sion [5], affecting primarily the small intestine, stomach,
and colon [4, 12]. However, some gastrointestinal melano-
mas remain undocumented and without evidence of a
primary lesion, cutaneous or elsewhere, even after a thor-
ough examination [13].The incidence of metastatic gastro-
intestinal melanoma of unknown primary origin is from 4
to 9% in case series [14]. In order to distinguish between
primary and metastatic intestinal melanoma, Bender et al.
were able to identify four different types of metastatic
melanoma of the small intestine based solely on histo-
pathological features: cavitary, infiltrating, eccentric, and
polypoid [15]. Lymphocytic infiltrate with melanophages,
restorative fibrosis, and a vascular proliferation present in
the dermis are commonly seen in intestinal metastatic
melanoma developed after spontaneous regression of the
primary cutaneous lesion [6]. To make the diagnosis of
primary malignant melanoma of the small intestine, other
authors recommend excluding any history of melanoma
in the other major sites. Sacks et al. established three diag-
nostic criteria: (1) single lesion, (2) no metastatic location
other than in the regional lymph nodes, (3) relapse-free
survival of more than 1 year after diagnosis [16].
In our case, histological study confirmed the diagno-
sis of intestinal melanoma with concordant immuno-
histochemical profile; our patient had no history of
cutaneous melanoma, and etiological examination found
no other melanoma lesion. At 1-year follow-up, clinical
examination and abdominal CT scan control showed no
intraperitoneal signs of recurrence. The diagnosis of a pri-
mary malignant melanoma of the small bowel has been
established.
Adjuvant systemic therapy has a limited role, different
chemotherapy regimens have been applied but the response
rates were extremely low [6]. In our case, no adjuvant ther-
apy was administered.
Conclusions
The diagnosis of primary intestinal melanoma can be con-
firmed based on the criteria described in the literature;
however, early diagnosis and surgical resection are essen-
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Fig. 4 Large tumoral malignant cell proliferation with melanin
pigmentations infiltrating the small bowel wall. Hematoxylin and
eosin, ×100
Fig. 5 Tumor cells are positive in immunohistochemical staining
for HMB-45
Fig. 6 Tumor cells are positive in immunohistochemical staining
for S-100
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